MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement
MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting [Yahoo! Finance]
MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
Clinical Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 39th Annual Meeting
MAIA Biotechnology Announces $2.44 Million Private Placement